STEPHANIE STOCKTON: Open Payments
NPI 1104458108 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 66 payments from 11 companies in 2025. Trend: 2023 $911 · 2024 $1,104 · 2025 $1,153
Food & beverage: $1,042Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $284 |
| Otsuka America Pharmaceutical, Inc. | 12 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $188 |
| Teva Pharmaceuticals USA, Inc. | 8 | $180 |
| Vanda Pharmaceuticals Inc. | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Alkermes, Inc. | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: INGREZZA, REXULTI, CAPLYTA, FANAPT, AUSTEDO XR, COBENFY, ARISTADA, Jornay PM.
Industry payments across TX — which companies pay providers there.
